Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie G Buffie

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Reviews. Immunology|October 8, 2013
Microbiota-mediated colonization resistance against intestinal pathogensCharlie G Buffie, Eric G Pamer
Infection and Immunity|October 19, 2011
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitisCharlie G Buffie, Irene Jarchum, Michele Equinda, et al.
Plos Computational Biology|December 19, 2013
Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiotaRichard R Stein, Vanni Bucci, Nora C Toussaint, et al.
The Journal of Infectious Diseases|April 30, 2015
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With MetronidazoleBrittany B Lewis, Charlie G Buffie, Rebecca A Carter, et al.
Immunity|February 7, 2012
Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defenseMelissa A Kinnebrew, Charlie G Buffie, Gretchen E Diehl, et al.
Science Translational Medicine|February 26, 2016
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcusMichael C Abt, Charlie G Buffie, Bože Sušac, et al.
Cell Reports|March 26, 2025
Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infectionKevin S Mears, Joshua E Denny, Jeffrey R Maslanka, et al.
Nature|October 23, 2014
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileCharlie G Buffie, Vanni Bucci, Richard R Stein, et al.
Journal of the American College of Cardiology|September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR ProjectCharles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Reviews. Immunology|October 8, 2013
Microbiota-mediated colonization resistance against intestinal pathogensCharlie G Buffie, Eric G Pamer
Infection and Immunity|October 19, 2011
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitisCharlie G Buffie, Irene Jarchum, Michele Equinda, et al.
Plos Computational Biology|December 19, 2013
Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiotaRichard R Stein, Vanni Bucci, Nora C Toussaint, et al.
The Journal of Infectious Diseases|April 30, 2015
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With MetronidazoleBrittany B Lewis, Charlie G Buffie, Rebecca A Carter, et al.
Immunity|February 7, 2012
Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defenseMelissa A Kinnebrew, Charlie G Buffie, Gretchen E Diehl, et al.
Science Translational Medicine|February 26, 2016
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcusMichael C Abt, Charlie G Buffie, Bože Sušac, et al.
Cell Reports|March 26, 2025
Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infectionKevin S Mears, Joshua E Denny, Jeffrey R Maslanka, et al.
Nature|October 23, 2014
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileCharlie G Buffie, Vanni Bucci, Richard R Stein, et al.
Journal of the American College of Cardiology|September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR ProjectCharles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.
Pageof 1